pm-01183 and Endometrial-Neoplasms

pm-01183 has been researched along with Endometrial-Neoplasms* in 1 studies

Trials

1 trial(s) available for pm-01183 and Endometrial-Neoplasms

ArticleYear
Lurbinectedin in patients with pretreated endometrial cancer: results from a phase 2 basket clinical trial and exploratory translational study.
    Investigational new drugs, 2023, Volume: 41, Issue:5

    Topics: Antineoplastic Combined Chemotherapy Protocols; Carbolines; Doxorubicin; Endometrial Neoplasms; Female; Humans; Neutropenia

2023